Website of the Department of Health

On vCJD transmission through blood components: reconciling modelled risks with case evidence

EOR has modelled the possible secondary transmission of vCJD via blood and blood components. This paper attempts to test the plausibility of infectivity estimates (provided by consultants DNV) used so far to generate baseline scenarios for blood-borne infection. It argues that the resulting scenarios do appear to 'over-predict' the possible number of infections via blood components, though the many unknowns surrounding vCJD may prevent a definitive test. Please see preface for further details and commentary.

• Download preface (PDF, 91K)
• Download On vCJD transmission through blood components: reconciling modelled risks with case evidence (PDF, 238K)
• Exclusion of blood component recipients from donation: the impact on potential vCJD transmission risks